KB
Krishna Bandi
About Krishna Bandi
Data last updated:
Krishna Bandi is a Director at Gnanamayee Pharmaceuticals Private Limited (since 2023). The company operates in Healthcare. Gnanamayee Pharmaceuticals Private Limited reported revenue of ₹24.6 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Apr 2023 | 2023 | ₹24.6 Lakh (FY 2024) | Active |
Board colleagues of Krishna Bandi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Krishna Chaitanya Gorantla | 10111026 | Gnanamayee Pharmaceuticals Private Limited | Director |
| Raghuveer Machiraju | 10111025 | Gnanamayee Pharmaceuticals Private Limited | Director |
| Srinivas Reddy Badvel | 08951569 | Gnanamayee Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Krishna Bandi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Krishna Bandi
Krishna Bandi currently holds 1 directorship: Gnanamayee Pharmaceuticals Private Limited (Director, since 11 Apr 2023, revenue ₹24.6 Lakh (FY 2024)).
Krishna Bandi was first appointed on 11 Apr 2023 as Director at Gnanamayee Pharmaceuticals Private Limited.
The current boards of Krishna Bandi's companies include Krishna Chaitanya Gorantla (Gnanamayee Pharmaceuticals Private Limited), Raghuveer Machiraju (Gnanamayee Pharmaceuticals Private Limited), Srinivas Reddy Badvel (Gnanamayee Pharmaceuticals Private Limited).